Medistim ASA (OSL: MEDI)

Market Cap	3.12B
Revenue (ttm)	533.17M
Net Income (ttm)	104.34M
Shares Out	18.31M
EPS (ttm)	5.70
PE Ratio	29.91
Forward PE	27.03
Dividend	4.50 (2.64%)
Ex-Dividend Date	Apr 25, 2024

Volume	3,760
Open	165.00
Previous Close	165.00
Day's Range	162.50 - 170.50
52-Week Range	146.50 - 237.00
Beta	0.88
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 24, 2024

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Europe, Asia, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1984
• Employees: 151
• Stock Exchange: Oslo Børs
• Ticker Symbol: MEDI

Financial Performance

In 2023, Medistim ASA's revenue was 521.11 million, an increase of 7.17% compared to the previous year's 486.26 million. Earnings were 103.82 million, a decrease of -8.91%.